The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deceivingly, this chimeric construct appears to be fully functional, as it phosphorylates canonical substrates, forms holoenzymes, responds to cAMP activation, and recognizes the endogenous inhibitor PKI.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [13]
In the citing paper
“In vivo enzymatic assays, as well as conventional in vitro coupled assays, have shown that the kinetic parameters of PKA-CWT and PKA-CDNAJB1 are similar7,13,15.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [13]
In the citing paper
“Moreover, PKA-CDNAJB1 retains the ability to form stable holoenzymes with all regulatory (R) subunit isoforms, although with non-canonical arrangements, and more importantly, responds to cAMP activation13,14.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [13]
In the citing paper
“Interestingly, the RIα subunit is overexpressed in carcinoma cells, presumably to “buffer” the PKA-CDNAJB1 overexpression6,13,37.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Research works printed but not linked: 37
- Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010;42 Suppl 3:S206–14. · DOI · Paper page
- Hoshida Y. Molecular signatures and prognosis of hepatocellular carcinoma. Minerva Gastroenterol Dietol 2011;57:311–22.
- Kan Z, Zheng H, Liu X, et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res 2013;23:1422–33. · DOI · Paper page
- Qi LN, Li LQ, Chen YY, et al. Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China. PLoS One 2013;8:e83465. · doi:10.1371/journal.pone.0083465
- Mayo SC, Mavros MN, Nathan H, et al. Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective. J Am Coll Surg 2014;218:196–205. · DOI
- Torbenson M. Fibrolamellar carcinoma: 2012 update. Scientifica (Cairo) 2012;2012:743790.
- Honeyman JN, Simon EP, Robine N, et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science 2014;343:1010–4. · DOI · Paper page
- Xu L, Hazard FK, Zmoos AF, et al. Genomic analysis of fibrolamellar hepatocellular carcinoma. Hum Mol Genet 2015;24:50–63. · DOI · Paper page
- Cheung J, Ginter C, Cassidy M, et al. Structural insights into mis-regulation of protein kinase A in human tumors. Proc Natl Acad Sci USA 2015;112:1374–9. · DOI · Paper page
- Amieux PS, McKnight GS. The essential role of RI alpha in the maintenance of regulated PKA activity. Ann N Y Acad Sci 2002;968:75–95. · DOI · Paper page
- Uhler MD, McKnight GS. Expression of cDNAs for two isoforms of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem 1987;262:15202–7. · DOI · Paper page
- Dell’Acqua ML, Scott JD. Protein kinase A anchoring. J Biol Chem 1997;272:12881–4. · DOI · Paper page
- Scott JD, Pawson T. Cell signaling in space and time: where proteins come together and when they’re apart. Science 2009;326:1220–4. · DOI · Paper page
- Pritchard CC, Salipante SJ, Koehler K, et al. Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens. J Mol Diagn 2014;16:56–67. · DOI · Paper page
- Newlon MG, Roy M, Hausken ZE, Scott JD, Jennings PA. The A-kinase anchoring domain of type IIalpha cAMP-dependent protein kinase is highly helical. J Biol Chem 1997;272:23637–44. · DOI
- Wu J, Brown SH, von Daake S, Taylor SS. PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity. Science 2007;318:274–9. · DOI · Paper page
- Zick SK, Taylor SS. Interchain disulfide bonding in the regulatory subunit of cAMP-dependent protein kinase I. J Biol Chem 1982;257:2287–93. · DOI
- Scott JD, Stofko RE, McDonald JR, Comer JD, Vitalis EA, Mangili JA. Type II regulatory subunit dimerization determines the subcellular localization of the cAMP-dependent protein kinase. J Biol Chem 1990;265:21561–6. · DOI · Paper page
- Carnegie GK, Means CK, Scott JD. A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 2009;61:394–406. · DOI · Paper page
- Smith FD, Reichow SL, Esseltine JL, et al. Intrinsic disorder within an AKAP-protein kinase A complex guides local substrate phosphorylation. Elife 2013;2:e01319. · DOI
- Scott JD, Fischer EH, Demaille JG, Krebs EG. Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1985;82:4379–83. · DOI · Paper page
- Scott JD, Glaccum MB, Fischer EH, Krebs EG. Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1986;83:1613–6. · DOI · Paper page
- Welch EJ, Jones BW, Scott JD. Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 2010;10:86–97. · DOI · Paper page
- Beuschlein F, Fassnacht M, Assié G, et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N Engl J Med 2014;370:1019–28. · DOI · Paper page
- Carnegie GK, Scott JD. A-kinase anchoring proteins and neuronal signaling mechanisms. Genes Dev 2003;17:1557–68. · DOI
- Lania AG, Mantovani G, Ferrero S, et al. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Res 2004;64:9193–8. · DOI
- Mantovani G, Bondioni S, Ferrero S, et al. Effect of cyclic adenosine 3’,5’-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2005;90:6721–4. · DOI
- Riehle KJ, Yeh MM, Yu JJ, et al. mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma. Mod Pathol 2015;28:103–10. · DOI
- Pringle DR, Vasko VV, Yu L, et al. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice. J Clin Endocrinol Metab 2014;99:E804–12. · DOI
- Canton DA, Keene CD, Swinney K, et al. Gravin is a transitory effector of polo-like kinase 1 during cell division. Mol Cell 2012;48:547–59. · DOI
- Carnegie GK, Soughayer J, Smith FD, et al. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell 2008;32:169–79. · DOI
- Langeberg LK, Scott JD. Signalling scaffolds and local organization of cellular behaviour. Nat Rev Mol Cell Biol 2015;16:232–44. · DOI · Paper page
- Smith FD, Langeberg LK, Cellurale C, et al. AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat Cell Biol 2010;12:1242–9. · DOI
- Sunahara RK, Dessauer CW, Whisnant RE, Kleuss C, Gilman AG. Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase. J Biol Chem 1997;272:22265–71. · DOI · Paper page
- Collier NA, Weinbren K, Bloom SR, Lee YC, Hodgson HJ, Blumgart LH. Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1984;1:538–40. · doi:10.1016/s0140-6736(84)90934-6
- Dan YY, Riehle KJ, Lazaro C, et al. Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci USA 2006;103:9912–7. · DOI · Paper page
- Voet D, Voet JG. Biochemistry. 3rd edn. New York, NY: Wiley, 2004:480.
Cited by
Liquid–liquid phase separation drives cellular function and dysfunction in cancer
Mehta, S., & Zhang, J. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00444-7 · Cited by 437
Phase Separation of a PKA Regulatory Subunit Controls cAMP Compartmentation and Oncogenic Signaling
Zhang, J. Z., Lu, T.-W., Stolerman, L. M., Tenner, B., Yang, J. R., Zhang, J.-F., Falcke, M., Rangamani, P., Taylor, S. S., Mehta, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.043 · Cited by 314
Olivieri, C., Walker, C., Karamafrooz, A., Wang, Y., Manu, V. S., Porcelli, F., Blumenthal, D. K., Thomas, D. D., Bernlohr, D. A., Simon, S. M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01819-6 · Cited by 27
Metadata
- Authors
- Riggle, K. M., Riehle, K. J., Kenerson, H. L., Turnham, R., Homma, M. K., Kazami, M., Samelson, B., Bauer, R., McKnight, G. S., Scott, J. D., & Yeung, R. S.
- Venue
- Pediatric Research
- Published
- 2016-03-08
- Volume
- 80
- Issue
- 1
- Pages
- 110-118
- ISSN
- 0031-3998
- 1530-0447
- Cited by
- 50
- References
- 1
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma. https://app.cochat.ai/papers/10.1038/pr.2016.36
- The paper
- Riggle, K. M., Riehle, K. J., Kenerson, H. L., Turnham, R., Homma, M. K., Kazami, M., Samelson, B., Bauer, R., McKnight, G. S., Scott, J. D., & Yeung, R. S. (2016). Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma. Pediatric Research. https://doi.org/10.1038/pr.2016.36
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.